In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)

Background: To evaluate the in vitro dose delivery characteristics of approved asthma and chronic obstructive pulmonary disease (COPD) therapies delivered via the ELLIPTA(®) dry powder inhaler across inhalation endpoints representative of the target patient population, using the Electronic Lung (eLu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Melanie, Leggett, Richard, Pang, Cheng, Charles, Stephen, Gillett, Ben, Prime, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685503/
https://www.ncbi.nlm.nih.gov/pubmed/26372465
http://dx.doi.org/10.1089/jamp.2015.1225

Ejemplares similares

Ejemplares similares